| Literature DB >> 1331944 |
Abstract
The treatment of asthma is changing to reflect the importance of inflammation in the disease pathogenesis. Medicines that alter the inflammatory response are the cornerstone of therapy for patients with persistent symptoms. Bronchodilators are important in acute care, but in chronic illness they are adjuvant therapy. Patient education is essential for successful outcome.Entities:
Mesh：
Substances：
Year: 1992 PMID： 1331944 DOI： 10.1016/s0031-3955(16)38446-2
Source DB: PubMed Journal: Pediatr Clin North Am ISSN： 0031-3955 Impact factor: 3.278